Talk-based overdose prevention for people using opioids
Part of Immune system & allergy, Infections, Mental health clinical trials.
This trial tests an overdose prevention approach for people who have used opioids recently. It aims to help reduce the risk of overdose by offering a structured prevention intervention.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have used opioids in the past 2 weeks
- You are currently using drugs (as part of recent opioid use)
- You can take part in the intervention and follow instructions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a program where people who use opioids learn to educate their friends and family about overdose prevention. It may help build a safer support network in Baltimore.
This study tests a better way to start long-acting HIV prevention (PrEP) and buprenorphine for opioid use disorder while people are in jail, to see if it helps them stay healthy after release. If you are soon leaving jail and have opioid use disorder, you may be able to join.
This pilot program studies where HIV risk is highest and uses that information to decide how prevention efforts should be delivered. If you’ve used opioids recently and you inject drugs, you may be invited to participate to help reduce HIV risk.
This study helps adults who recently left jail, prison, or similar facilities and have risks related to opioid use or HIV. It aims to connect them with treatment and care support starting from the emergency department.
This study helps addiction clinics offer tools and support for safer drug use to prevent HIV and other infections. It aims to see if these services are helpful and easy to use for patients who inject drugs.
This trial tests whether naltrexone, a medication that blocks the effects of opioids, can help prevent overdose in people who use stimulants like cocaine or methamphetamine. It may be a good fit if you are at risk for HIV or living with HIV, and have a stimulant use disorder or use stimulants at least 10 days per month.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.